Inaya Therapeutics

Inaya Therapeutics is a privately-held biopharmaceutical company focused on developing breakthrough inhaled therapies with the potential to significantly improve current treatment paradigms for rare cardiopulmonary conditions. The team collectively brings decades of experience in successfully developing cardiopulmonary, inhaled and/or other therapies on a variety of advanced platforms, and includes world class expertise in clinical, pre-clinical, commercial, CMC, corporate development, regulatory/quality and intellectual property. The company is developing a pipeline of therapies for PAH as well as other cardiopulmonary indications.